Posted inCardiology Clinical Updates Gastroenterology
Plozasiran: A Novel siRNA Therapy Reducing Severe Hypertriglyceridemia and Pancreatitis Risk
Plozasiran, targeting APOC3 mRNA, significantly lowers triglyceride levels and reduces acute pancreatitis incidence in severe hypertriglyceridemia patients, according to pooled data from two placebo-controlled trials.